Table 3 Adverse events recorded following children treatment with ASAQ (n = 262) and AL (n = 261) in Togo, 2012–2013
ASAQ | AL | |||
|---|---|---|---|---|
n | (%) | n | (%) | |
Number of children | 262 | 100 | 261 | 100 |
Adverse events | ||||
Diarrhoea | 1 | (0.38) | 2 | (0.77) |
Abscess | 0 | (0.00) | 1 | (0.38) |
Asthenia | 1 | (0.38) | 1 | (0.38) |
Anorexia | 1 | (0.38) | 0 | (0.00) |
Haemoglobinuria | 0 | (0.00) | 1 | (0.38) |
Itching | 1 | (0.38) | 1 | (0.38) |
Eyelid oedema | 0 | (0.00) | 1 | (0.38) |
Total | 4 | (1.53) | 7 | (2.68) |